Navigation Links
Clemson researchers develop hands-free texting application
Date:2/16/2010

CLEMSON, S.C. Clemson University researchers have developed a hands-free alternative to cell phone texting while driving.

"If you can't keep people from doing it, make it safer," said Juan Gilbert, professor and chairman of the human-centered computing division of Clemson's School of Computing.

He said one problem with banning texting while driving is that people are likely to continue doing it. He said it will be difficult for police to can't enforce a ban unless they actually see someone in the act. Gilbert said evidence of texting while driving often surfaces only after an accident.

Gilbert's team developed an application, called VoiceTEXT, that allows drivers to speak text messages and keep their eyes on the road at the same time. Drivers using VoiceTEXT put their cell phones in Bluetooth mode and connect it to their car.

"Through the car's speaker system or through the driver's own Bluetooth headset, drivers can give a voice command that delivers a text message," Gilbert said. "So you can speak to your phone and tell it to send a message to an individual. The recipient's phone recognizes the voice as a text message and the other person is able to respond appropriately."


'/>"/>

Contact: Juan Gilbert
juan@clemson.edu
864-656-4846
Clemson University
Source:Eurekalert

Page: 1

Related medicine news :

1. Ozen Engineering Inc. donates human body-modeling software to Clemson
2. DOE funds Clemson University clean energy research
3. CDC awards Clemson researcher $700,000 to study black lung prevention
4. Clemson awarded $2M to study radiation-induced bone loss
5. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
6. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
7. Researchers create drug to keep tumor growth switched off
8. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
9. Researchers discover new way to kill pediatric brain tumors
10. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
11. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2016)... ... December 10, 2016 , ... The ... PATS recently joined forces with other healthcare organizations to promote diabetes education at ... in Harrisburg, featured a variety of speakers from around the Commonwealth of Pennsylvania. ...
(Date:12/9/2016)... , ... December 09, 2016 , ... ... and aural rehabilitation—provided by audiologists—to remain a critical part of public access to ... Drug Administration (FDA) announced this week that, starting immediately, it would ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... miniature, folded, pharmaceutical inserts and outserts. As a means of expanding capabilities ... addition will enable Flottman to individually code professional inserts (PIs) and patient package ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... its 10th anniversary with the grand opening of the Sober College Robert Pfeifer ... spanned two days, December 2-3, and was attended by an overwhelming amount of ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... Ball at The Pierre Hotel in New York, NY, on December 3rd, to ... dignitaries and physicians attended the annual event, which raised over $1 million - ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)...  Eli Lilly and Company (NYSE: LLY ... EXPEDITION3 trial at the 9 th Clinical Trials ... did not meet the primary endpoint in the EXPEDITION3 ... with mild dementia due to Alzheimer,s disease (AD), and ... the treatment of mild dementia due to AD. ...
(Date:12/8/2016)... QUEBEC CITY , Dec. 8, 2016 /PRNewswire/ ... key US patents for improving the accuracy, reproducibility ... CD images in long and small bone orthopaedic ... proprietary approach to creating personalized orthopaedic restorations based ... create personalized orthopaedic restorations, the company harnesses the ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, ... has obtained proof-of-mechanism for neflamapimod (previously code named ... Phase 2a clinical trials that demonstrated significant Alzheimer,s ... 302 (12-week treatment) and Study 303 (6-week treatment) ... Trials in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: